Compounds > gadolinium
Page last updated: 2024-08-22

gadolinium and Hepatitis

gadolinium has been researched along with Hepatitis in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19901 (11.11)18.7374
1990's1 (11.11)18.2507
2000's6 (66.67)29.6817
2010's1 (11.11)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kalb, B; Kitajima, HD; Martin, DR; Sharma, P1
Alberti, R; Altissimo, M; Arfelli, F; Clai, M; Delfino, R; Frizzi, T; Klatka, T; Longoni, A; Lorusso, V; Menk, RH; Pascolo, L; Salomè, M; Tiribelli, C; Tromba, G; Vaccari, L1
MAGNUSSON, G1
Bronk, SF; Canbay, A; Feldstein, AE; Gores, GJ; Grambihler, A; Higuchi, H; Werneburg, N1
Martin, DR; Semelka, RC1
Granado, M; López-Calderón, A; Martín, AI; Priego, T; Villanúa, MA1
Kobayashi, K; Kuwata, T; Matsuura, M; Sasaki, H; Yajima, T; Yamaguchi, M1
Chaudry, IH; Edwards, CK; Hsu, HC; Li, L; Matsuki, Y; Mountz, JD; Yang, PA; Zhang, HG; Zheng, R1
Levine, BA; McCollum, MO; Olson, MS; Zhou, W1

Reviews

2 review(s) available for gadolinium and Hepatitis

ArticleYear
Gadolinium-enhanced imaging of liver tumors and manifestations of hepatitis: pharmacodynamic and technical considerations.
    Topics in magnetic resonance imaging : TMRI, 2009, Volume: 20, Issue:2

    Topics: Contrast Media; Gadolinium; Hepatitis; Humans; Image Enhancement; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Metabolic Clearance Rate

2009
Magnetic resonance imaging of the liver: review of techniques and approach to common diseases.
    Seminars in ultrasound, CT, and MR, 2005, Volume: 26, Issue:3

    Topics: Contrast Media; Fatty Liver; Gadolinium; Hemochromatosis; Hepatitis; Humans; Image Enhancement; Liver; Liver Diseases; Magnetic Resonance Imaging

2005

Other Studies

7 other study(ies) available for gadolinium and Hepatitis

ArticleYear
X-ray fluorescence elemental mapping and microscopy to follow hepatic disposition of a Gd-based magnetic resonance imaging contrast agent.
    Clinical and experimental pharmacology & physiology, 2011, Volume: 38, Issue:12

    Topics: Animals; Contrast Media; Fatty Liver; Female; Gadolinium; Hepatitis; Iron; Liver; Magnetic Resonance Imaging; Mice; Mice, Inbred CBA; Organometallic Compounds; Spectrometry, X-Ray Emission

2011
THE BEHAVIOR OF CERTAIN LANTHANONS IN RATS.
    Acta pharmacologica et toxicologica, 1963, Volume: 20

    Topics: Cerium; Chemical and Drug Induced Liver Injury; Dysprosium; Erbium; Europium; Gadolinium; Hepatitis; Hepatitis A; Histocytochemistry; Holmium; Injections; Injections, Intravenous; Kidney; Lanthanum; Liver; Lutetium; Metabolism; Neodymium; Praseodymium; Promethium; Radioisotopes; Rats; Research; Samarium; Scandium; Terbium; Thulium; Toxicology; Ytterbium

1963
Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression.
    Hepatology (Baltimore, Md.), 2003, Volume: 38, Issue:5

    Topics: Animals; Apoptosis; Bile Ducts; Cytokines; Fas Ligand Protein; Gadolinium; Hepatitis; Hepatocytes; Kupffer Cells; Ligation; Liver; Liver Cirrhosis; Membrane Glycoproteins; Mice; Phagocytosis; Tumor Necrosis Factor-alpha

2003
Inactivation of Kupffer cells by gadolinium administration prevents lipopolysaccharide-induced decrease in liver insulin-like growth factor-I and IGF-binding protein-3 gene expression.
    The Journal of endocrinology, 2006, Volume: 188, Issue:3

    Topics: Adrenocorticotropic Hormone; Animals; Blotting, Northern; Blotting, Western; Body Weight; Cell Survival; Gadolinium; Hepatitis; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Kupffer Cells; Lipopolysaccharides; Male; Nitrates; Nitrites; Rats; Rats, Wistar; Receptors, Somatotropin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Necrosis Factor-alpha

2006
Lactoferrin protects against development of hepatitis caused by sensitization of Kupffer cells by lipopolysaccharide.
    Clinical and diagnostic laboratory immunology, 2001, Volume: 8, Issue:6

    Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents; Gadolinium; Hepatitis; Humans; Injections, Intravenous; Kupffer Cells; Lactoferrin; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; Recombinant Proteins; Tumor Necrosis Factor-alpha; Zymosan

2001
Soluble Fas gene therapy protects against Fas-mediated apoptosis of hepatocytes but not the lethal effects of Fas-induced TNF-alpha production by Kupffer cells.
    Cell death and differentiation, 2002, Volume: 9, Issue:6

    Topics: Animals; Antibodies; Apoptosis; fas Receptor; Female; Gadolinium; Genetic Therapy; Hemorrhage; Hepatitis; Hepatocytes; Immunohistochemistry; Kupffer Cells; Liver; Male; Mice; Mice, Inbred C57BL; Solubility; Tumor Necrosis Factor-alpha

2002
Inflammation and platelet-activating factor production during hepatic ischemia/reperfusion.
    Hepatology (Baltimore, Md.), 1992, Volume: 16, Issue:5

    Topics: Alanine Transaminase; Allopurinol; Animals; Azepines; Gadolinium; Hepatitis; Ischemia; Leukocytes; Liver; Male; Necrosis; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Triazoles

1992